Skip to content

Switzerland logo

Main menu
  • Home
    • Wer wir sind
    • Wofür wir stehen
    • Transparenz bei Organon
    • Geschäftspartner:innen
    • Unsere Schwerpunkte
    • Produktübersicht
  • Organon im Dialog
  • Karriere

Kontakt

Zurück
Change Language
  • English
  • Français
Main menu

Organon site directory

  • Organon

    • Brazil
    • Canada  English  ·  French
    • Latin America
    • Mexico
    • USA
  • Organon

    • Austria
    • Belgium  Dutch  ·  English  ·  French
    • Bulgaria
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg  English  ·  French
    • Netherlands  Dutch  ·  English
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland  French  ·  German  ·  English
    • Ukraine  Ukrainian  · 
    • United Kingdom
  • Organon

    • Australia
    • Hong Kong, China
    • Indonesia
    • Japan
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Organon

    • Egypt
    • Israel
    • Jordan
    • KSA
    • Kuwait
    • Lebanon
    • Northwest Africa  French  ·  Arabic  ·  Turkey
    • Oman
    • South Africa
    • Turkey
    • UAE
View all locations and contact information

Was suchen Sie?

Search for:

We're turning #IWD into #IWDayOFF

We have a clear mission: to empower women through our daily work. This attitude motivates our approximately 10,000 employees every day to develop products that enable women around the world to live healthier and better lives. But women's health is not a clear focus in medicine or in society. That's why we don't just celebrate International Women's Day, but make it a day off for all employees worldwide.

We are sending a clear signal for women's health

Companies like us also have a responsibility to use our resources and opportunities to help make the world a fairer place. Fairer for everyone. But especially for women.

Drei lachende Frauen IWDayOFF

More focus on women's health

That’s why on March 8, 2023, we’re deliberately giving our colleagues a whole day to take care of their health – and that of their loved ones.

This is why on this day it is up to our employees whether they take care of their own mental health and that of their loved ones, or whether they commit themselves to a special project close to their hearts. This means that on March 8, we are consciously taking the time to strengthen women’s health. Because we want to take the time to help empower women and fight outdated prejudices.

This is what Christoph Habereder, Managing Director, Organon D-A-CH, says

„With our daily work, we want to support women and create more space for their individual health needs. But that alone is not enough. Political unrest and wars, the pandemic, and social injustice continue to ensure that discrimination against women happens every day – and it happens everywhere.

The relevance for women’s health must be discussed more in the future, especially medically. But not only that. Pharmaceutical companies like us must also take a social and political stand on the issue. And not just on International Women’s Day, but every day. Our campaign is designed to make that clear. That’s why we’re turning International Women’s Day into an International Women’s Day Off. This does not mean that we do nothing on March 8, 2023, but the opposite. We are taking the time to do something for everyone’s health. Nothing could be more important these days.“ #IWDayOFF

Bild von Christoph Habereder, Managing Director, Organon

"To empower women's health, we need to do big things. And we need to do it every day."

Christoph Habereder, Managing Director, Organon D-A-CH

Switzerland logo
  • Impressum
  • Nutzungsbedingungen
  • AGB
  • Cookie Policy
  • Privacy Policy
© 2025 Organon group of companies. All rights reserved.

You are leaving Organon.com

Cancel Continue Opens a new window

Forward-looking statement of Organon

This news release of Organon (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov Opens a new window ).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept